Ultrasound vendor Hewlett-Packard has developed an upgrade packagefor its HP Sonos 2500 scanner that optimizes the system for harmonicimaging, an experimental technique based on the use of ultrasoundcontrast media. The Andover, MA, company will not sell
Ultrasound vendor Hewlett-Packard has developed an upgrade packagefor its HP Sonos 2500 scanner that optimizes the system for harmonicimaging, an experimental technique based on the use of ultrasoundcontrast media. The Andover, MA, company will not sell the newsystem to clinicians, but rather will lease it to pharmaceuticalcompanies for research purposes.
In harmonic imaging, researchers tune the ultrasound transducerto receive only echoes that are harmonics of the primary ultrasoundtransmission (SCAN 12/27/95). This can improve contrast detectionin certain cases.
The new scanner, HP Sonos 2500 LE, includes hardware and softwarethat allow the system to transmit at one frequency and receiveat another, according to Denis Bonaccolta, product manager. Pharmaceuticalcompanies developing harmonic applications for contrast agentsshould find the system useful, Bonaccolta said. These companieswould rather lease a scanner than buy one because they would haveno use for the unit once the research is completed.
In addition to harmonic imaging, Sonos 2500 LE includes softwarefor acoustic densitometry (AD), a method of quantitatively measuringgray-scale levels in ultrasound images. This should also proveuseful to pharmaceutical companies in assembling product approvalapplications to the Food and Drug Administration for their agents.
"The fact that we can give numbers with AD strengthens (thecompanies') presentations to the FDA, because they can give quantitativedata on contrast enhancement," Bonaccolta said.
In other news, HP debuted a new 3-D acquisition software packageat the American Society of Echocardiography last month. The package,also for HP's Sonos 2500 scanner, is designed to provide 3-D imagesof the cardiac chambers, the size of cardiac abnormalities, andsegmental wall motion. Images acquired by the scanner are transferredto a magneto-optical disk, and then to an off-line system for3-D reconstruction. HP will sell the acquisition package for $27,500.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.